Related Experiment Videos
Systemic conditions associated with areca nut usage: a literature review
Fawad Javed1, Fernanda O Bello Correra, Milisha Chotai
1Eng.A.B. Growth Factors and Bone Regeneration Research Centre, King Saud University, Riyadh, Saudi Arabia. fawjav@gmail.com
Scandinavian Journal of Public Health
|August 7, 2010
Summary
Areca nut (AN) chewing harms systemic health, impacting vital organs. This review details AN
Area of Science:
- Oral Health and Systemic Conditions
- Public Health Research
- Toxicology
Background:
- Areca nut (AN) chewing is linked to oral health issues.
- Systemic health risks associated with AN chewing are not widely reviewed.
- Understanding AN's systemic impact is crucial for public health.
Purpose of the Study:
- To review systemic conditions associated with areca nut (AN) usage.
- To consolidate evidence on the non-oral health hazards of AN chewing.
- To address the question: 'What are the deleterious effects of AN usage on systemic health?'
Main Methods:
- Systematic review of MEDLINE PubMed databases (1966-May 2010).
- Inclusion criteria: human studies, AN users, controls, English language articles.
- Hand-searching was also performed to identify relevant literature.
Main Results:
- Included 28 articles detailing AN's systemic effects.
- AN chewing linked to cardiovascular and cerebrovascular disorders.
- Associated with metabolic issues (obesity, hyperglycemia, metabolic syndrome, type 2 diabetes), hepatic, oesophageal, respiratory, and renal disorders.
- Adverse effects on birth outcomes were also noted.
Conclusions:
- Areca nut (AN) chewing significantly impacts systemic health.
- AN usage adversely affects multiple vital organs.
- The habit poses a considerable risk to overall well-being beyond oral health.
Related Concept Videos
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...